Cancer Drugs May Damage the Heart - Chi Mei Hospital Initiates Asia's First Cardio-Oncology Care Program
The team tracked the cardiac index of breast cancer patients using echocardiography and serum analysis during the acute, subacute, and chronic phase of drug injection and notified the oncologist as soon as any abnormality is detected. By closely tracking the heart function, the hope is to allow patients to undergo chemotherapy without the need to worry.
Chi Mei Hospital established its cardio-oncology team in 2014. The team tracked patients on doxorubicin chemotherapy and found that about 10 to 30% of the patients suffered from damage to the heart. If the cardiotoxicity due to the cancer treatment could be diagnosed early and its mechanisms understood, there is the possibility to treat the patients in a timely manner and improve their quality of life. As such, the team tracked the cardiac index of breast cancer patients using echocardiography and serum analysis during the acute, subacute, and chronic phase of drug injection and notified the oncologist as soon as any abnormality is detected. By closely tracking the heart function, the hope is to allow patients to undergo chemotherapy without the need to worry.
When patients with malignant tumors undergo chemotherapy, the focus is normally on the efficacy of the drug, the response of the tumor, and whether immediate side effects exist. However, as pointed out by Dr. Wei-Ting Chang of the Department of Cardiology at Chi Mei Hospital, chemotherapy drugs (including targeted drugs) may act on other cells in the body in addition to acting on the tumors. Specifically, cardiotoxicity occurs in 5 to 20% of the patients according to clinical statistics. These types of complications are severe and fatal but diagnosis and intervention are often too late.
Chi Mei Hospital's program allows doctors to perform appropriate treatments while keeping patients well informed of the condition of their hearts through follow-up phone calls and patient education. The precious data accumulated through this program also offer an opportunity for translational research. By separating the biomarkers in the serum and through advanced speckle-tracking echocardiography analysis, a method for detecting biomarkers in patients was established to allow early identification of patients susceptible to cardiotoxicity.
The Director of the Department of Cardiology at Chi Mei Hospital, Dr. Zhih-Cherng Chen, noted that the field of cardio-oncology began in Europe and the Americas over 10 years ago and its importance is now recognized worldwide. However, research in the field is rare in Asia. Unlike techniques such as cardiac catheterization and stents which are mainstream in cardiology, few young doctors are willing to devote themselves to the work. Nevertheless, "if it's the right thing to do, then it deserves the effort," as reflected in the cardio-oncology program that has already improved patient treatment and quality of life.
(Editing by Nicole Yang, Research Center for Biotechnology and Medicine Policy)
Innovative Respiratory Control System allows Radiotherapy more Precise Hitting
The technique can reduce the treatment volume by accurately targeting to the lesion sites without unnecessarily injury surrounding normal tissues.
Taiwan's Authority in Bone Cancer Treatment and Reconstruction Pioneers New Cryotherapy Techniques
Many bone tumor centers in the world use liquid nitrogen cryotherapy as a precision adjuvant therapy to minimize recurrence of the tumor. As traditional methods see complications in as high as 19% of the cases, Dr. Wu began to develop new techniques. In 2014, Dr. Wu succeeded in developing a method using low-temperature solid ethanol to treat bone sarcoma. The method not only improves upon the shortcomings of using liquid nitrogen but also has been verified to lower the complication rate.